Iron Deficiency Anemia Diagnosis and Management

Laboratory Interpretation

Hemoglobin, hematocrit, and RBC count are significantly below normal ranges, confirming anemia in patients with iron deficiency 1, 2
Serum iron is low, indicating iron deficiency in individuals with anemia 3
Transferrin saturation is borderline low, suggesting impaired iron mobilization 3, 4
Ferritin is normal, but can be falsely elevated in inflammatory states, making it essential to consider the entire clinical picture 4, 1
MCV is normal, indicating a normocytic anemia rather than microcytic anemia 1, 2

Functional iron deficiency occurs when the body has adequate iron stores but cannot mobilize iron for erythropoiesis, often seen in patients with chronic diseases 3, 5
Iron deficiency with concurrent inflammation can lead to falsely normal ferritin levels, highlighting the need for careful interpretation of iron studies 4, 1
Early iron deficiency may present with normal ferritin levels despite depleted functional iron, emphasizing the importance of monitoring iron parameters 4, 6
The British Society of Gastroenterology guidelines suggest that ferritin values below 100 μg/L may indicate iron deficiency in inflammatory states 4

Oral iron supplementation with ferrous sulfate is recommended, with a target dose of 65 mg elemental iron daily, and monitoring of hemoglobin response 2, 7
Investigation of underlying causes, including gastrointestinal blood loss, celiac disease, and chronic inflammatory conditions, is crucial for effective management 6, 5
Intravenous iron may be considered in patients with poor response to oral iron, intolerance, or presence of chronic inflammatory conditions 7, 5, 8

A therapeutic trial of iron can be both diagnostic and therapeutic, allowing for monitoring of hemoglobin response and adjustment of treatment 2, 7
Normal MCV does not exclude iron deficiency, especially in early stages or when combined with other conditions affecting red cell size 1
The entire clinical picture and iron panel should be considered when evaluating iron deficiency, rather than relying solely on ferritin levels 4

Moderate anemia (hemoglobin ≈ 8 g/dL) in adults warrants urgent correction. 9
Transferrin saturation of ~ 6 % indicates severe iron‑restricted erythropoiesis and absolute iron deficiency. 10

For a 70 kg adult, the calculated iron deficit is roughly 1,200–1,500 mg elemental iron, requiring multiple IV infusions. (formula‑based estimate; no direct citation)

A total of 10–12 weekly Ferrlecit infusions (125 mg elemental iron each; 1,250–1,500 mg total) is recommended to replete stores. 11

Re‑evaluate iron studies 3–4 weeks after completing the initial 6–8 infusions. 11
Desired transferrin saturation after repletion: 20–50 %. 10
Desired ferritin after repletion: 100–500 ng/mL. 9
Expected hemoglobin increase: 1–2 g/dL within 4–6 weeks of therapy. 12

Weeks 1–6: Administer 125 mg Ferrlecit weekly (6 infusions ≈ 750 mg total). 11
Weeks 7–12: Continue weekly 125 mg infusions only if transferrin saturation remains < 20 % and ferritin < 500 ng/mL. 13
Week 12: Anticipate hemoglobin rise to approximately 10–11 g/dL. 9

Intravenous iron yields superior hemoglobin responses (≈ 73–93 % response) compared with oral iron (≈ 41–45 % response) in severe deficiency. 12
Erythropoiesis‑stimulating agents (ESAs) should be considered only after iron repletion (transferrin saturation > 20 % and ferritin > 100 ng/mL). 14

Red blood cell transfusion is indicated for symptomatic patients (e.g., severe fatigue, dyspnea, chest pain) or when hemoglobin falls below 7–8 g/dL before iron therapy can take effect. 15